Delphine Fouquenet
Tours, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Neutralizing human monoclonal antibodies that target the PcrV component of the type III secretion system of Pseudomonas aeruginosa act through distinct mechanisms.
Journal: eLife
Published: February 17, 2026
Condition-dependent effects of Elexacaftor/Tezacaftor/Ivacaftor (Trikafta) on Aspergillus fumigatus growth.
Journal: Microbiology spectrum
Published: July 30, 2025
Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signaling.
Journal: EMBO molecular medicine
Published: January 17, 2025
Directed-complement killing of Pseudomonas aeruginosa protects against lethal pneumonia.
Journal: EBioMedicine
Published: December 19, 2024
Preventive nasal administration of flagellin restores antimicrobial effect of gentamicin and protects against a multidrug-resistant strain of Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: March 25, 2024
Poly-L-Lysine to Fight Antibiotic Resistances of Pseudomonas aeruginosa.
Journal: International journal of molecular sciences
Published: December 28, 2022
Treatment of Pseudomonas aeruginosa Biofilm Present in Endotracheal Tubes by Poly-l-Lysine.
Journal: Antimicrobial agents and chemotherapy
Published: March 22, 2018
Lack of FcRn Impairs Natural Killer Cell Development and Functions in the Tumor Microenvironment.
Journal: Frontiers in immunology
Published: March 08, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026